Erratum: Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy (Clin Cancer Res (2019) 12(4916–4924)Doi:10.1158/1078-0432.CCR-06-0021)

Jyotsnabaran Halder; Aparna A. Kamat; Charles N. Landen; Liz Y. Han; Susan K. Lutgendorf; Yvonne G. Lin; William M. Merritt; Nicholas B. Jennings; Arturo Chavez-Reyes; Robert Coleman; David M Gershenson; Rosemarie Schmandt; Steven W. Cole; Gabriel Lopez-Berestein; Anil K. Sood

doi:10.1158/1078-0432.CCR-19-1132

Erratum: Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy (Clin Cancer Res (2019) 12(4916–4924)Doi:10.1158/1078-0432.CCR-06-0021)

Jyotsnabaran Halder, Aparna A. Kamat, Charles N. Landen, Liz Y. Han, Susan K. Lutgendorf, Yvonne G. Lin, William M. Merritt, Nicholas B. Jennings, Arturo Chavez-Reyes, Robert Coleman, David M Gershenson, Rosemarie Schmandt, Steven W. Cole, Gabriel Lopez-Berestein, Anil K. Sood

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Abstract

In the original version of this article (1), Fig. 4B included an incorrect IHC panel for CD31 with FAK siRNA þ docetaxel. The error has been corrected in the latest online PDF version of the article. The authors regret this error. Reference 1. Halder J, Kamat AA, Landen CN Jr, Han LY, Lutgendorf SK, Lin YG, et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res 2006;12:4916–24.

Original language	English (US)
Pages (from-to)	3194
Number of pages	1
Journal	Clinical Cancer Research
Volume	25
Issue number	10
DOIs	https://doi.org/10.1158/1078-0432.CCR-19-1132
State	Published - 2019

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-19-1132

Fingerprint

Dive into the research topics of 'Erratum: Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy (Clin Cancer Res (2019) 12(4916–4924)Doi:10.1158/1078-0432.CCR-06-0021)'. Together they form a unique fingerprint.

Cite this

Halder, J., Kamat, A. A., Landen, C. N., Han, L. Y., Lutgendorf, S. K., Lin, Y. G., Merritt, W. M., Jennings, N. B., Chavez-Reyes, A., Coleman, R., Gershenson, D. M., Schmandt, R., Cole, S. W., Lopez-Berestein, G., & Sood, A. K. (2019). Erratum: Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy (Clin Cancer Res (2019) 12(4916–4924)Doi:10.1158/1078-0432.CCR-06-0021). Clinical Cancer Research, 25(10), 3194. https://doi.org/10.1158/1078-0432.CCR-19-1132

Erratum: Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy (Clin Cancer Res (2019) 12(4916–4924)Doi:10.1158/1078-0432.CCR-06-0021). / Halder, Jyotsnabaran; Kamat, Aparna A.; Landen, Charles N. et al.
In: Clinical Cancer Research, Vol. 25, No. 10, 2019, p. 3194.

Research output: Contribution to journal › Comment/debate › peer-review

Halder, J, Kamat, AA, Landen, CN, Han, LY, Lutgendorf, SK, Lin, YG, Merritt, WM, Jennings, NB, Chavez-Reyes, A, Coleman, R, Gershenson, DM, Schmandt, R, Cole, SW, Lopez-Berestein, G & Sood, AK 2019, 'Erratum: Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy (Clin Cancer Res (2019) 12(4916–4924)Doi:10.1158/1078-0432.CCR-06-0021)', Clinical Cancer Research, vol. 25, no. 10, pp. 3194. https://doi.org/10.1158/1078-0432.CCR-19-1132

@article{cda745ef58c945e28c93875c3c9b78bc,

title = "Erratum: Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy (Clin Cancer Res (2019) 12(4916–4924)Doi:10.1158/1078-0432.CCR-06-0021)",

abstract = "In the original version of this article (1), Fig. 4B included an incorrect IHC panel for CD31 with FAK siRNA {\th} docetaxel. The error has been corrected in the latest online PDF version of the article. The authors regret this error. Reference 1. Halder J, Kamat AA, Landen CN Jr, Han LY, Lutgendorf SK, Lin YG, et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res 2006;12:4916–24.",

author = "Jyotsnabaran Halder and Kamat, {Aparna A.} and Landen, {Charles N.} and Han, {Liz Y.} and Lutgendorf, {Susan K.} and Lin, {Yvonne G.} and Merritt, {William M.} and Jennings, {Nicholas B.} and Arturo Chavez-Reyes and Robert Coleman and Gershenson, {David M} and Rosemarie Schmandt and Cole, {Steven W.} and Gabriel Lopez-Berestein and Sood, {Anil K.}",

note = "Publisher Copyright: {\textcopyright} 2019 American Association for Cancer Research.",

year = "2019",

doi = "10.1158/1078-0432.CCR-19-1132",

language = "English (US)",

volume = "25",

pages = "3194",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "10",

}

TY - JOUR

T1 - Erratum

T2 - Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy (Clin Cancer Res (2019) 12(4916–4924)Doi:10.1158/1078-0432.CCR-06-0021)

AU - Halder, Jyotsnabaran

AU - Kamat, Aparna A.

AU - Landen, Charles N.

AU - Han, Liz Y.

AU - Lutgendorf, Susan K.

AU - Lin, Yvonne G.

AU - Merritt, William M.

AU - Jennings, Nicholas B.

AU - Chavez-Reyes, Arturo

AU - Coleman, Robert

AU - Gershenson, David M

AU - Schmandt, Rosemarie

AU - Cole, Steven W.

AU - Lopez-Berestein, Gabriel

AU - Sood, Anil K.

PY - 2019

Y1 - 2019

N2 - In the original version of this article (1), Fig. 4B included an incorrect IHC panel for CD31 with FAK siRNA þ docetaxel. The error has been corrected in the latest online PDF version of the article. The authors regret this error. Reference 1. Halder J, Kamat AA, Landen CN Jr, Han LY, Lutgendorf SK, Lin YG, et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res 2006;12:4916–24.

AB - In the original version of this article (1), Fig. 4B included an incorrect IHC panel for CD31 with FAK siRNA þ docetaxel. The error has been corrected in the latest online PDF version of the article. The authors regret this error. Reference 1. Halder J, Kamat AA, Landen CN Jr, Han LY, Lutgendorf SK, Lin YG, et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res 2006;12:4916–24.

UR - http://www.scopus.com/inward/record.url?scp=85065777132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065777132&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-19-1132

DO - 10.1158/1078-0432.CCR-19-1132

M3 - Comment/debate

C2 - 31092618

AN - SCOPUS:85065777132

SN - 1078-0432

VL - 25

SP - 3194

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 10

ER -

Erratum: Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy (Clin Cancer Res (2019) 12(4916–4924)Doi:10.1158/1078-0432.CCR-06-0021)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this